ClinicalTrials.gg
Not yet recruitingNCT07926529Updated Nov 9, 2026

The Effect of Laughter Therapy on the Quality of Life and Psychological Well-being of Nursing Students

An interventional study of Laughter Therapy in Laughter Therapy, Quality Of Life and Psychological Well-Being, sponsored by Çankırı Karatekin University. Not yet recruiting at 1 site in Turkey (Türkiye). Per ClinicalTrials.gov, last updated 2026-11-09.

Sponsored by Çankırı Karatekin University · Not applicable, Interventional, and Treatment

Updated Nov 9, 2026Newly registeredGo to Updates ↓
Phase
Not applicable
Study type
Interventional
Enrollment
56
Allocation
Randomized
Sex
All
01

Study summary

The nursing profession is a healthcare discipline that combines theoretical knowledge with clinical practice skills. The primary aim of nursing education is to train healthcare professionals who are prepared for the profession, aware of their duties and responsibilities, and capable of providing effective care to individuals and the community. During their education, nursing students face various challenges both in the academic sphere and in clinical settings. Students are confronted with numerous stressors, such as a heavy course load, preparing for examinations, undertaking clinical placements, a lack of self-confidence, and the changes brought about by the university environment. When this process is not managed effectively, it is thought that students' quality of life and psychological well-being may be adversely affected. Accordingly, there is a need for complementary health approaches to enhance nursing students' quality of life and to safeguard and promote their psychological well-being. Included among these complementary health approaches, laughter therapy has physiological and psychological effects on individuals. There are numerous positive effects associated with laughter, such as improving cognitive functions, enhancing respiration, increasing pain tolerance, improving sleep quality, reducing exam anxiety and lowering stress hormone levels.

Accordingly, the aim of this thesis is to investigate the effect of laughter therapy administered to nursing students on their quality of life and psychological well-being. A review of the literature revealed no existing studies on this topic. Consequently, it is anticipated that this planned thesis will make a significant contribution to filling this gap in the literature.

The study is planned as a randomised controlled experimental study using a pre-test-post-test-follow-up design. The research will be conducted with second-year nursing students at the Faculty of Health Sciences, Çankırı Karatekin University. A total of 112 students who meet the inclusion criteria and are allocated to the experimental (n=56) and control (n=56) groups via randomisation will form the study sample. Experimental group students will undergo a laughter therapy programme comprising a total of eight sessions, at a rate of two sessions per week; the control group will receive no intervention during the study period. Session times will be planned together with the students in the experimental group who will receive laughter therapy. Research data will be collected using the Demographic Information Form, the SF-12 Quality of Life Scale and the Psychological Well-being Scale. IBM SPSS Statistics for Windows, Version 24.0, will be used to analyse the data obtained from this study.

02

Conditions studied

  • Laughter Therapy
  • Quality Of Life
  • Psychological Well-Being

Keywords

  • laughter therapy
  • quality of life
  • psychological well-being
03

In context

Psychological Well-Being

2,193 studies on the registry are indexed under Psychological Well-Being; 728 are open to participants now.

This study's planned enrollment of 56 is below the median of 110 across 1,796 interventional studies indexed under Psychological Well-Being.

Browse Psychological Well-Being studies →

Lead sponsor

Çankırı Karatekin University is the lead sponsor of 65 studies on the registry; 20 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
Child (0–17), Adult (18–64), Older adult (65+)
Sexes eligible
All
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Be a second-year nursing student in the Department of Nursing at Çankırı Karatekin University
  • Be able to speak and understand Turkish
  • Have no diagnosed psychiatric disorders
  • Have no communication difficulties
  • Agree to participate in laughter therapy sessions
  • Have no history of using psychotropic medications, either currently or in the past

Exclusion criteria

Exclusion Criteria:

  • Failure to attend all laughter therapy sessions
  • Having a physical condition that would prevent participation in laughter therapy sessions
  • Having previously participated in laughter therapy
  • Using medication or another nonpharmacological method to reduce stress
  • Having difficulty performing breathing exercises
  • Not volunteering to participate in the study
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
56 participants (estimated)

Study arms

  • Experimental
    Laughter Therapy Group

    Behavioral: Laughter Therapy

  • No intervention
    No-Intervention Control Group

Interventions

  • BehavioralLaughter Therapy

    Experimental group students will undergo a laughter therapy programme comprising a total of eight sessions, at a rate of two sessions per week; the control group will receive no intervention during the study period. The days and times for the laughter therapy sessions to be conducted with the experimental group will be planned in consultation with the students. The sessions will be held in a suitable classroom or conference room with the participants seated in a U-shaped arrangement. During the first session, students will receive a brief introduction and information about the activities to be conducted throughout the session. Each session aims to encourage spontaneous laughter by incorporating breathing exercises, rhythmic clapping and vocal exercises, playful and energetic games, "icebreaker laughter," and guided meditation. Each session is scheduled to last approximately 40 minutes.

06

What researchers measure

Primary outcomes

  1. Change in quality of life measured by the 12-item Quality of Life Scale

    The scale was developed by Ware et al. in 1995. A validity and reliability study conducted by Soylu and Kütük in 2002 demonstrated that it is a measurement tool with adequate psychometric properties for assessing general health status and health-related quality of life in clinical practice and scientific research. The scale comprises 12 items across eight sub-dimensions: physical functioning (2 items), physical role (2 items), bodily pain (1 item), general health (1 item), energy (1 item), social functioning (1 item), emotional role (2 items) and mental health (2 items). Items relating to physical and emotional roles are answered on a dichotomous basis (yes or no), whilst the other items are measured on a Likert scale ranging from 3 to 6. A score of 100 on the scale indicates the best state of health, whilst a score of 0 indicates the worst state of health. In the Turkish validity and reliability study, the Cronbach's alpha coefficient was determined to be between 0.92 and 0.88.

    Time frame: Baseline (before the intervention) and immediately after completion of the intervention

Secondary outcomes

  1. Change in psychological well-being measued by the 8-item Psychological Well-being Scale

    The scale identifies key elements of human functioning, ranging from positive relationships to feelings of competence and leading a meaningful and purposeful life. It was developed by Diener and colleagues in 2009. The adaptation into Turkish was carried out by Telef in 2011. In the reliability study of the scale, the Cronbach's alpha internal consistency coefficient was calculated as .80 The items on the Psychological Well-being Scale are rated on a scale of 1 to 7, ranging from 'I strongly disagree' (1) to 'I strongly agree' (7). All items are phrased in positive terms. Scores range from 8 to 56. A high score indicates that the individual possesses a wide range of psychological resources and strengths. Although the scale does not provide separate measurements of the various dimensions of well-being, it offers a general overview of positive functioning across different areas that we believe to be important.

    Time frame: Baseline (before the intervention) and immediately after completion of the intervention

07

Study locations

1 site
  • Cankiri Kaatekin University
    Çankırı, Çankırı, Turkey (Türkiye)
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Timeline

1 registry update since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Start is estimated for Nov 2026; primary completion for Dec 2026, 1 month later.

Of 1,259 non-industry interventional studies with no phase under Psychological Well-Being, half reached primary completion within 17 months of starting (the median), counting those still running; a quarter within 7 and three quarters within 34. This study's planned 1 month is below that.

Counting every sponsor, half of 1,302 studies reached it within 16 months; a quarter within 7 and three quarters within 34.

How these figures are worked out, and which studies are left out of them.

Registered
Oct 28, 2026
First posted
Nov 9, 2026
StartEst.
Nov 2026
Primary completionEst.
Dec 2026
CompletionEst.
Feb 2027
Last update
Nov 9, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Registered
First appeared on the registry. No changes since
Nov 9, 2026
Show all 1 update
  1. Nov 9, 2026
    First appeared on the registry

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT07926529
Lead sponsor
Çankırı Karatekin University
Responsible party
Fahriye Şeyma Kara (master's student in nursing, Çankırı Karatekin University) — Principal investigator
First posted
Nov 9, 2026
Start date
Nov 2026 (estimated)
Primary completion
Dec 2026 (estimated)
Completion
Feb 2027 (estimated)
Last update
Nov 9, 2026

Study contacts

fahriye s kara
Contact
248426003@ogrenci.karatekin.edu.tr
+90 539 210 49 71
fahriye s kara
principal investigator · Çankırı Karatekin University
mevlut karatas, professor
study director · Çankırı Karatekin University

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Nov 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion